Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism in which immune cell activation is induced by the cross-linking of CD16 with the Fc region of antibodies that at the same time bind specifically to cell surface antigens. ADCC stimulates the secretion of perforin, granzymes, and cytokines leading to lysis of the malignant cells. Natural killer (NK) cells express the CD16 receptor and can therefore be activated by ADCC to kill tumor cells. To study the cytotoxicity of NK cells against cancer cells, an ADCC-based assay is described: the chromium release assay. In this method, the antibody trastuzumab, which binds specifically to HER2-positive malignant cells, is used to trigger ADCC.
Key wordsAntibody cell-mediated cytotoxicity Natural killer cells Trastuzumab Chromium release assay
- 1.Yamashita M, Kitano S, Aikawa H, Kuchiba A, Hayashi M, Yamamoto N et al (2016) A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells. Sci Rep 6:19772. https://doi.org/10.1038/srep19772CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Abbas A, Lichtman AH, Pillai S (2014) Cellular and molecular immunology, 8th edn. ElsevierGoogle Scholar
- 6.Yu L, Wang Y, Yao Y, Li W, Lai Q, Li J et al (2014) Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model. Int J Gynecol Cancer 24(7):1158–1164. https://doi.org/10.1097/igc.0000000000000179CrossRefPubMedGoogle Scholar
- 7.Tak W, Mak MES (2006) MHC: the major histocompatibility complex. The immune response. ElsevierGoogle Scholar
- 11.Adams S, Alving B, Anderson KC, AuBuchon JP, Bandarenko N, Barrett J et al (2007) Contributors. In: Blood banking and transfusion medicine, 2nd edn. Churchill Livingstone, Philadelphia, pp vii–xiii. https://doi.org/10.1016/B978-0-443-06981-9.50003-XCrossRefGoogle Scholar